Stryker Corporation
Stryker Corporation Completes $2.311 Billion Euro and USD Notes Offerings
Summary
On September 11, 2024, Stryker Corporation completed a public offering of €800 million aggregate principal amount of 3.375% Notes due 2032 and €600 million aggregate principal amount of 3.625% Notes due 2036 (Euro Notes) and $750 million aggregate principal amount of 4.250% Notes due 2029 and $750 million aggregate principal amount of 4.625% Notes due 2034 (USD Notes). The Euro Notes and USD Notes were issued under separate indentures and underwriting agreements. The Company expects to use the net proceeds to repay existing debt and for general corporate purposes. All documents related to the offerings are filed as exhibits to this 8-K report.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (10)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement